Leuko-Glycemic Index in the Prognosis of Acute Myocardial Infarction; a Cohort Study on Coronary Angiography and Angioplasty Registry

Overview

Journal Arch Acad Emerg Med

Specialty Emergency Medicine

Date 2023 Oct 16

PMID 37840868

Authors

Roxana Sadeghi

Mohammad Haji Aghajani

Reza Parandin

Niloufar Taherpour

Koohyar Ahmadzadeh

Arash Sarveazad

Affiliations

Soon will be listed here.

Abstract

Introduction: The leuko-glycemic index (LGI), a combined index of patient leukocyte counts and blood glucose levels, has been shown to predict the prognosis of myocardial infarction (MI) patients. Our study aims to investigate the performance of LGI in prediction of outcomes in a population of diabetic and non-diabetic MI patients.

Methods: This observational registry-based cohort study was performed on acute myocardial infarction (AMI) patients. Participants were sub-grouped according to their diabetes status and the calculated optimal LGI cut-off value. The outcomes of the study were the length of hospital stay, and in-hospital and 30-day mortality.

Results: A total of 296 AMI (112 diabetic and 184 non-diabetic) patients were included in the study. The optimal cut-off value of LGI in the diabetic and non-diabetic groups was calculated as 2970.4 mg/dl.mm and 2249.4 mg/dl.mm, respectively. High LGI was associated with increased hospital admission duration in non-diabetic patients (p = 0.017). The area under the curve (AUC) of LGI for prediction of in-hospital mortality was 0.93 (95% CI: 0.87 to 1.00) in the diabetic group and 0.92 (95% CI: 0.85 to 0.99) in the non-diabetic group. LGI had a sensitivity and specificity of 90.00%, and 93.14% in prediction of in-hospital mortality in the diabetic group compared to 77.77% and 90.85% in the non-diabetic group. We observed 4 post-discharge mortalities in our patient group.

Conclusion: Our study demonstrated that higher LGI predicts in-hospital mortality in both diabetic and non-diabetic patients, while the length of hospital stay was only predicted by LGI levels in non-diabetic patients.

Citing Articles

Leukoglycemic Index and Its Prognostic Implications in Diabetic and Nondiabetic Patients with Acute Pulmonary Embolism.

Aslan N, Guneysu F, Yurumez Y, Guner N, Akdeniz S, Kaner M Med Sci Monit. 2025; 31:e947156.

PMID: 39885679 PMC: 11792369. DOI: 10.12659/MSM.947156.

Elevated Leukocyte Glucose Index Is Associated with Long-Term Arteriovenous Fistula Failure in Dialysis Patients.

Muresan A, Florea E, Arbanasi E, Bartus R, Arbanasi E, Ion A J Clin Med. 2024; 13(7).

PMID: 38610802 PMC: 11012331. DOI: 10.3390/jcm13072037.

A Look at Archives of Academic Emergency Medicine Journal in 2023.

Yazdanbakhsh M, Saghaei Dehkordi S Arch Acad Emerg Med. 2024; 12(1):e21.

PMID: 38572219 PMC: 10988183. DOI: 10.22037/aaem.v12i1.2250.

References

. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159):1736-1788. PMC: 6227606. DOI: 10.1016/S0140-6736(18)32203-7. View

Kounis N, Soufras G, Tsigkas G, Hahalis G . White blood cell counts, leukocyte ratios, and eosinophils as inflammatory markers in patients with coronary artery disease. Clin Appl Thromb Hemost. 2014; 21(2):139-43. DOI: 10.1177/1076029614531449. View

Wang X, Zhang F, Zhang C, Zheng L, Yang J . The Biomarkers for Acute Myocardial Infarction and Heart Failure. Biomed Res Int. 2020; 2020:2018035. PMC: 6988690. DOI: 10.1155/2020/2018035. View

Thygesen K, Alpert J, Jaffe A, Chaitman B, Bax J, Morrow D . Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018; 138(20):e618-e651. DOI: 10.1161/CIR.0000000000000617. View

Seropian I, Sonnino C, Van Tassell B, Biasucci L, Abbate A . Inflammatory markers in ST-elevation acute myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2015; 5(4):382-95. DOI: 10.1177/2048872615568965. View

Fang L, Moore X, Dart A, Wang L . Systemic inflammatory response following acute myocardial infarction. J Geriatr Cardiol. 2015; 12(3):305-12. PMC: 4460175. DOI: 10.11909/j.issn.1671-5411.2015.03.020. View

Ruparelia N, Chai J, Fisher E, Choudhury R . Inflammatory processes in cardiovascular disease: a route to targeted therapies. Nat Rev Cardiol. 2016; 14(3):133-144. PMC: 5525550. DOI: 10.1038/nrcardio.2016.185. View

Seoane L, Burgos L, Espinoza J, Furmento J, Benzadon M, Vrancic J . Prognostic Value of the Leuko-Glycaemic Index in the Postoperative Period of Coronary Artery Bypass Grafting. Braz J Cardiovasc Surg. 2021; 36(4):484-491. PMC: 8522313. DOI: 10.21470/1678-9741-2020-0349. View

Leon-Aliz E, Moreno-Martinez F, Perez-Fernandez G, Vega-Fleites L, Rabassa-Lopez-Calleja M . [Leuko-glycemic index as an in-hospital prognostic marker in patients with ST-segment elevation myocardial infarction]. Clin Investig Arterioscler. 2014; 26(4):168-75. DOI: 10.1016/j.arteri.2014.01.002. View

10.

Ray K, Seshasai S, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D . Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet. 2009; 373(9677):1765-72. DOI: 10.1016/S0140-6736(09)60697-8. View

11.

Chen Y, Tao Y, Zhang L, Xu W, Zhou X . Diagnostic and prognostic value of biomarkers in acute myocardial infarction. Postgrad Med J. 2019; 95(1122):210-216. DOI: 10.1136/postgradmedj-2019-136409. View

12.

Ladeira R, Baracioli L, Faulin T, Saes Parra Abdalla D, Seydell T, Maranhao R . Unrecognized diabetes and myocardial necrosis: predictors of hyperglycemia in myocardial infarction. Arq Bras Cardiol. 2013; 100(5):404-11. View

13.

Deckers J, van Domburg R, Akkerhuis M, Nauta S . Relation of admission glucose levels, short- and long-term (20-year) mortality after acute myocardial infarction. Am J Cardiol. 2013; 112(9):1306-10. DOI: 10.1016/j.amjcard.2013.06.007. View

14.

Khan M, Hashim M, Mustafa H, Baniyas M, Al Suwaidi S, AlKatheeri R . Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study. Cureus. 2020; 12(7):e9349. PMC: 7384703. DOI: 10.7759/cureus.9349. View

15.

Qi L, Liu H, Cheng L, Luo Y, Yang S, Chen X . Prognostic Value of the Leuko-Glycemic Index in Acute Myocardial Infarction Patients with or without Diabetes. Diabetes Metab Syndr Obes. 2022; 15:1725-1736. PMC: 9191833. DOI: 10.2147/DMSO.S356461. View

16.

Barron H, Harr S, Radford M, Wang Y, Krumholz H . The association between white blood cell count and acute myocardial infarction mortality in patients > or =65 years of age: findings from the cooperative cardiovascular project. J Am Coll Cardiol. 2001; 38(6):1654-61. DOI: 10.1016/s0735-1097(01)01613-8. View

17.

Yang J, Zheng Y, Li C, Gao J, Meng X, Zhang K . The Impact of the Stress Hyperglycemia Ratio on Short-term and Long-term Poor Prognosis in Patients With Acute Coronary Syndrome: Insight From a Large Cohort Study in Asia. Diabetes Care. 2022; 45(4):947-956. DOI: 10.2337/dc21-1526. View

18.

Meissner J, Irfan A, Twerenbold R, Mueller S, Reiter M, Haaf P . Use of neutrophil count in early diagnosis and risk stratification of AMI. Am J Med. 2011; 124(6):534-42. DOI: 10.1016/j.amjmed.2010.10.023. View

19.

Zhao D . Epidemiological Features of Cardiovascular Disease in Asia. JACC Asia. 2022; 1(1):1-13. PMC: 9627928. DOI: 10.1016/j.jacasi.2021.04.007. View

20.

Sadeghi R, Dizaji S, Vazirizadeh-Mahabadi M, Sarveazad A, Forouzannia S . Prognostic Value of The Leuko-Glycemic Index in Acute Myocardial Infarction; a Systematic Review and Meta-Analysis. Arch Acad Emerg Med. 2023; 11(1):e25. PMC: 10008249. DOI: 10.22037/aaem.v11i1.1915. View